<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>OBY on CMC Seoul OBY &amp; Breast Pathology</title>
    <link>https://extraordinary-tulumba-269604.netlify.app/tags/oby/</link>
    <description>Recent content in OBY on CMC Seoul OBY &amp; Breast Pathology</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 18 Jul 2022 00:00:00 +0000</lastBuildDate><atom:link href="https://extraordinary-tulumba-269604.netlify.app/tags/oby/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>L1 cell adhesion molecule Immunohistochemistry</title>
      <link>https://extraordinary-tulumba-269604.netlify.app/docs/oby/2022-07-18-l1-cell-adhesion-molecule-immunohistochemistry/</link>
      <pubDate>Mon, 18 Jul 2022 00:00:00 +0000</pubDate>
      
      <guid>https://extraordinary-tulumba-269604.netlify.app/docs/oby/2022-07-18-l1-cell-adhesion-molecule-immunohistochemistry/</guid>
      <description>L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results
https://doi.org/10.1016/j.ejca.2014.07.014
L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile
https://doi.org/10.1038/s41416-018-0187-6</description>
    </item>
    
    <item>
      <title>Lower Anogenital Squamous Terminology (LAST) for HPV-Associated Lesions</title>
      <link>https://extraordinary-tulumba-269604.netlify.app/docs/oby/2022-06-11-lower-anogenital-squamous-terminology-last-for-hpv-associated-lesions/</link>
      <pubDate>Sat, 11 Jun 2022 00:00:00 +0000</pubDate>
      
      <guid>https://extraordinary-tulumba-269604.netlify.app/docs/oby/2022-06-11-lower-anogenital-squamous-terminology-last-for-hpv-associated-lesions/</guid>
      <description>CAP guideline Lower Anogenital Squamous Terminology (LAST) for HPV-Associated Lesionshttps://www.cap.org/protocols-and-guidelines/cap-guidelines/current-cap-guidelines/cap-asccp-lower-anogenital-squamous-terminology-for-hpv-associated-lesions</description>
    </item>
    
    <item>
      <title>FIGO</title>
      <link>https://extraordinary-tulumba-269604.netlify.app/docs/oby/2022-06-10-figo-cancer-report-2021/</link>
      <pubDate>Fri, 10 Jun 2022 00:00:00 +0000</pubDate>
      
      <guid>https://extraordinary-tulumba-269604.netlify.app/docs/oby/2022-06-10-figo-cancer-report-2021/</guid>
      <description>FIGO Cancer Report 2021FIGO staging and reporthttps://www.figo.org/news/figo-cancer-report-2021
</description>
    </item>
    
  </channel>
</rss>
